Indication

Hodgkin's lymphoma

Hodgkin's lymphoma is a malignancy of the lymphatic system, most commonly originating from germinal center B lymphocytes within lymph nodes. Read more about Hodgkin's lymphoma

433 drugs 194 manufacturers

Advertisement

Drugs that treat it

Common Hodgkin's lymphoma therapies.

Showing 406–414 of 433 drugs

PREDNISONE

GLUCOCORTICOSTEROIDS·PULMONARY TUBERCULOSIS·+67
INA PHARMACEUTI

PREDNISOLONE

GLUCOCORTICOSTEROIDS·TRICHINOSIS·+59
CHARTWELL GOVER

PREDNISONE

GLUCOCORTICOSTEROIDS·PULMONARY TUBERCULOSIS·+67
Endo USA

PREDNISONE

GLUCOCORTICOSTEROIDS·PULMONARY TUBERCULOSIS·+67
ENOVACHEM MANUF
Filter & compare in the drug finder →Opens the drug finder with Hodgkin's lymphoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Hodgkin's lymphoma.

Hodgkin's lymphoma is a malignancy of the lymphatic system, most commonly originating from germinal center B lymphocytes within lymph nodes.

It primarily affects adolescents, young adults, and older individuals, classically presenting in supradiaphragmatic lymph node regions such as the cervical, supraclavicular, or mediastinal chains.

Pathophysiologically, it is defined by a sparse population of neoplastic, multinucleated Reed-Sternberg cells or their variants embedded within an abundant background of non-neoplastic inflammatory leukocytes.

Patients typically present with painless regional lymphadenopathy, frequently accompanied by systemic B symptoms including unexplained fevers, drenching night sweats, and unintentional weight loss.

Personalize your experience

Follow Hodgkin's lymphoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it